Pedro Henrique Las Casas: VTE After BCMA Directed CAR T-Cell Therapy in Multiple Myeloma
Pedro Henrique Las Casas, Researcher at Centre de Recherche Saint-Antoine (Sorbonne University–INSERM) and Professor of Internal Medicine at UFMG, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“I’m very happy to share the publication of another work in the British Journal of Haematology.
In this systematic review, we evaluated the incidence of venous thromboembolism in multiple myeloma patients treated with BCMA-directed CAR T-cell therapy, highlighting important gaps in reporting and interpretation of real-world data.”
Title: Venous thromboembolism in patients with multiple myeloma treated with B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy: A systematic review
Authors: Pedro Henrique Fernandes do Carmo Las Casas, Javier Marco-Ayala, Elmina-Eleftheria Lefkou, Thamiris Silva Soares, Mohammed A. Baghdadi, Prakasha Kempaiah, Jawed Fareed, Patrick Vandreden, Vania Hungria, Marina Marchetti, Anna Falanga, Laurent Garderet, Grigoris Gerotziafas
Read the Full Article on British Journal Of Haematology

Stay updated on all scientific advances with Hemostasis Today.
-
Feb 3, 2026, 14:26Anuoluwapo Babalola։ What The U.S. Exit from WHO Means for Global Health Leadership
-
Feb 3, 2026, 14:16Michiel Voet: Why Every Military Should Have a Dedicated Blood Unit
-
Feb 3, 2026, 10:53Aurelio Maggio: The Final Chapter of Our Journey Through Thalassemia
-
Feb 3, 2026, 10:40Pedro Perez: Post-Thrombectomy DVT Recovery in 2026 – Closing the Loop on Outcomes
-
Feb 3, 2026, 10:26Ryan Williams: This Article Brings to Light The Complexity of PRP…
-
Feb 3, 2026, 10:05Tiago Lopes: Can AI Predict Immune Reactions of New Drugs? Yes!
-
Feb 3, 2026, 09:51Rucha Patil Reflects on 49th MHG Annual Conference and Essence of ASH 2025
-
Feb 3, 2026, 09:37Grigoris Gerotziafas on VTE in MM and BCMA: We Are Pleased to Announce Our New Systematic Review
-
Feb 3, 2026, 09:24Early-Bird Registration for the WFH 2026 World Congress is Now Open